Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Chronic Renal Failure

Free Subscription Articles published in Kidney Int Retrieve available abstracts of 129 articles: HTML format

Single Articles

December 2027
1. FERRO CJ, Townend JN
   Atherosclerosis in chronic kidney disease-early prevention is better than late treatment.
   Kidney Int. 2027 Dec 5:S0085-2538(25)00954-8. doi: 10.1016/j.kint.2025.
   PubMed    
   
   
   
2. MASSY ZA
   The management of chronic kidney disease-associated cardiovascular complications should go beyond the management of traditional cardiovascular risk factors.
   Kidney Int. 2027 Dec 5:S0085-2538(25)00953-6. doi: 10.1016/j.kint.2025.
   PubMed    
   
   
   October 2026
3. CHAN EY, Cara-Fuentes G
   Frailty in children with chronic kidney disease and kidney failure.
   Kidney Int. 2026;110:781-783.
   PubMed     Abstract available
   
   
   
4. NIXON AC
   Comprehensive geriatric assessment for older people living with chronic kidney disease and frailty: time to set a new goal?
   Kidney Int. 2026;110:796-798.
   PubMed     Abstract available
   
   
   September 2026
5. LI Z, Li L, Li M, Zhang H, et al
   Stool from a Dormant Peritoneal Dialysis Catheter.
   Kidney Int. 2026 Sep 23:S0085-2538(26)00804-5. doi: 10.1016/j.kint.2026.
   PubMed    
   
   
   
6. WEIR MR, Bhaduri S, Lee K, Galvez O, et al
   Results from the Phase 2 Explore-CKD Trial of lorundrostat, a novel aldosterone synthase inhibitor, in participants with uncontrolled hypertension, chronic kidney disease, and albuminuria.
   Kidney Int. 2026 Sep 23:S0085-2538(26)00808-2. doi: 10.1016/j.kint.2026.
   PubMed     Abstract available
   
   
   
7. CHENG A, Wang Y, Liu Y, Xing X, et al
   The osteogenic regulator THOC5-dependent post-transcriptional control maintains vascular smooth muscle cell homeostasis against chronic kidney disease related vascular calcification.
   Kidney Int. 2026 Sep 23:S0085-2538(26)00809-4. doi: 10.1016/j.kint.2026.
   PubMed     Abstract available
   
   
   
8. AGBAS A, Canpolat N, Ranchin B, Schmitt CP, et al
   A randomized cross-over trial of pre-and post-filter hemodiafiltration modalities in children on maintenance dialysis -- effects on solute removal and blood pressure.
   Kidney Int. 2026 Sep 16:S0085-2538(26)00739-8. doi: 10.1016/j.kint.2026.
   PubMed     Abstract available
   
   
   
9. XING Z, Wang P, Zhang X, Zhang L, et al
   Skeletal oxalosis in a child on maintenance hemodialysis.
   Kidney Int. 2026 Sep 2:S0085-2538(26)00720-9. doi: 10.1016/j.kint.2026.
   PubMed    
   
   
   
10. TURNER ME, Aikawa E
    Toward multilevel therapeutic targeting of medial arterial calcification in chronic kidney disease.
    Kidney Int. 2026;110:529-532.
    PubMed     Abstract available
    
    
    August 2026
11. YEE-MOON WANG A, Disthabanchong S, Fukami K, Jafar TH, et al
    Asia-Pacific Summit on Implementation of Clinical Practice Guidelines on Diabetes and Blood Pressure Management in Chronic Kidney Disease: A KDIGO Summit Report.
    Kidney Int. 2026 Aug 27:S0085-2538(26)00715-5. doi: 10.1016/j.kint.2026.
    PubMed     Abstract available
    
    
    
12. ALLEN MR, Metzger CE, Chen NX, Srinivasan S, et al
    Combining dietary fiber inulin with parathyroid hormone-lowering therapy improves bone remodeling and mechanics in a rat model of Chronic Kidney Disease-Mineral Bone Disorder.
    Kidney Int. 2026 Aug 18:S0085-2538(26)00697-6. doi: 10.1016/j.kint.2026.
    PubMed     Abstract available
    
    
    
13. GAHEER PS, Lanktree MB
    Chronic kidney disease risk stratification using a proteomic risk score in apolipoprotein L1-mediated kidney disease.
    Kidney Int. 2026 Aug 3:S0085-2538(26)00627-7. doi: 10.1016/j.kint.2026.
    PubMed    
    
    
    
14. TANNOR EK, Luyckx VA, Abdelsalam M, Jerbi M, et al
    The AFRAN Prevention and Advocacy Group advocates for chronic kidney disease care: fulfilling the right to kidney health in Africa.
    Kidney Int. 2026;110:274-277.
    PubMed    
    
    
    July 2026
15. WAGNER S, A Massy Z, Koppe L
    From gut to uremic toxins: a not-so-innocent alliance between microbiota and enterocytes in chronic kidney disease.
    Kidney Int. 2026 Jul 21:S0085-2538(26)00594-6. doi: 10.1016/j.kint.2026.
    PubMed    
    
    
    
16. DE PASCALIS A, Vetrano D, Tomassetti A, La Manna G, et al
    Angiotensin receptor-neprilysin inhibitors for kidney protection in heart failure and chronic kidney disease: is there still a place?
    Kidney Int. 2026 Jul 7:S0085-2538(26)00499-0. doi: 10.1016/j.kint.2026.
    PubMed    
    
    
    
17. LAM CSP, Bozkurt B, Khan SS, Madero M, et al
    Authors' response to "Angiotensin receptor-neprilysin inhibitors for kidney protection in heart failure and chronic kidney disease: is there still a place?".
    Kidney Int. 2026 Jul 7:S0085-2538(26)00500-4. doi: 10.1016/j.kint.2026.
    PubMed    
    
    
    June 2026
18. XIAO D, Ning F, Lei H, Liu J, et al
    Peritoneal dialysis in a patient with extensive burn scarring.
    Kidney Int. 2026 Jun 26:S0085-2538(26)00510-7. doi: 10.1016/j.kint.2026.
    PubMed    
    
    
    
19. LOGAN B, Viecelli AK, Johnson DW, Comans T, et al
    A cluster randomized controlled trial (GOAL trial) evaluated a comprehensive geriatric assessment for frail older people with chronic kidney disease.
    Kidney Int. 2026 Jun 18:S0085-2538(26)00495-3. doi: 10.1016/j.kint.2026.
    PubMed     Abstract available
    
    
    
20. ANFT M, Paniskaki K, Franz D, Skrzypczyk S, et al
    Respiratory syncytial virus vaccination induces delayed but robust humoral and cellular immunity in patients receiving hemodialysis.
    Kidney Int. 2026 Jun 16:S0085-2538(26)00473-4. doi: 10.1016/j.kint.2026.
    PubMed     Abstract available
    
    
    
21. MOONEN L, Conte C, Van Campen E, Peired AJ, et al
    Strategic timing of contralateral nephrectomy after ischemic acute kidney injury prevents chronic kidney disease by enhancing progenitor proliferation, attenuating polyploidization and reshaping the immune response.
    Kidney Int. 2026 Jun 15:S0085-2538(26)00432-1. doi: 10.1016/j.kint.2026.
    PubMed     Abstract available
    
    
    
22. LIU J, Yang X, Zhang W, Wang J, et al
    The Calcified Cocoon: Obstructive Peritoneal Sclerosis in Peritoneal Dialysis.
    Kidney Int. 2026 Jun 10:S0085-2538(26)00430-8. doi: 10.1016/j.kint.2026.
    PubMed    
    
    
    
23. GATELY R, Wong G, Teixeira-Pinto A
    Techniques to predict survival outcomes in nephrology: basics and traditional methods.
    Kidney Int. 2026;109:1137-1147.
    PubMed     Abstract available
    
    
    May 2026
24. SHALL A, Hammer F, Vanhove T, Channaoui A, et al
    Giant renal allograft aneurysm: late detection and embolization.
    Kidney Int. 2026 May 20:S0085-2538(26)00393-5. doi: 10.1016/j.kint.2026.
    PubMed    
    
    
    
25. RIKIHISA T, Yoshimura Y, Oba Y, Hasegawa E, et al
    When kidneys can't be biopsied, skin biopsy identifies SLE relapse on dialysis.
    Kidney Int. 2026;109:1041.
    PubMed    
    
    
    
26. SUN XJ, Ma TT, Wang HY, Liu JG, et al
    Dynamic computed tomography peritoneography for the paracolic gutter leakage in peritoneal dialysis.
    Kidney Int. 2026;109:1040.
    PubMed    
    
    
    April 2026
27. KENTRUP D, Thomas JJ, Courbon G, Wang X, et al
    Estrogen protects female mice with chronic kidney disease from fibroblast growth factor 23-induced left ventricular hypertrophy.
    Kidney Int. 2026 Apr 27:S0085-2538(26)00309-1. doi: 10.1016/j.kint.2026.
    PubMed     Abstract available
    
    
    
28. CAZA TN, Charu V, Dai DF, Davis VG, et al
    Clinical and Histologic Predictors of Non-Diabetic Kidney Disease in Patients with Diabetes Mellitus.
    Kidney Int. 2026 Apr 23:S0085-2538(26)00305-4. doi: 10.1016/j.kint.2026.
    PubMed     Abstract available
    
    
    
29. NAKAGAWA Y, Onozawa Y, Kanai G, Nakamura M, et al
    Catheter malposition in a peritoneal dialysis patient with Chilaiditi sign.
    Kidney Int. 2026;109:801.
    PubMed    
    
    
    
30. RAJU S, Gollapudi SS, Senthilkumar T, Sunitha VC, et al
    The Case | A young man with medullary nephrocalcinosis and chronic kidney disease.
    Kidney Int. 2026;109:803-804.
    PubMed    
    
    
    March 2026
31. TOYE C, Brown PA, Canney M
    Migrating peritoneal dialysis catheter into an inguinal hernia.
    Kidney Int. 2026 Mar 6:S0085-2538(26)00062-1. doi: 10.1016/j.kint.2025.
    PubMed    
    
    
    
32. BNAYA A, Gomez D, Libdeh OA, Elayan N, et al
    Brown tumor of the patella in a long-term hemodialysis patient.
    Kidney Int. 2026;109:612.
    PubMed    
    
    
    
33. NASSIRI M, Parra-Londono F, Lopez-Baez V, Arango-Sancho P, et al
    Is it time to add a fifth pillar to the physical examination in pediatric dialysis?
    Kidney Int. 2026;109:608-609.
    PubMed    
    
    
    
34. LETOURNEAU P
    Causal claims require defined interventions: a note on the EQUAL chronic kidney disease-mineral and bone disorder analysis.
    Kidney Int. 2026;109:606-607.
    PubMed    
    
    
    
35. BIKBOV B
    Challenges in revealing the true incidence of end-stage kidney disease in the elderly population.
    Kidney Int. 2026;109:603-604.
    PubMed    
    
    
    
36. DELANAYE P, Mariat C
    Percentiles of estimating glomerular filtration rate: a new personalized tool for detection of chronic kidney disease.
    Kidney Int. 2026;109:436-438.
    PubMed     Abstract available
    
    
    February 2026
37. BARRACLOUGH KA, Berman-Parks N, Jha V, Piccoli GB, et al
    Green Dialysis: Environmentally Sustainable Care, Growth, and Innovation: Conclusions From a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2026 Feb 17:S0085-2538(26)00079-7. doi: 10.1016/j.kint.2026.
    PubMed     Abstract available
    
    
    
38. TING YT, Ooi JD
    Hybrid CARs: rewiring macrophage signaling for targeted therapy in acute and chronic kidney inflammation.
    Kidney Int. 2026 Feb 12:S0085-2538(26)00070-0. doi: 10.1016/j.kint.2026.
    PubMed    
    
    
    
39. CHANG FC, Lin SL
    Angiopoietin-2 inhibition and TIE2 reactivation in chronic kidney disease: the next step forward.
    Kidney Int. 2026 Feb 5:S0085-2538(26)00067-0. doi: 10.1016/j.kint.2025.
    PubMed    
    
    
    
40. FU SS, Tian ZX
    Pericatheter vascular calcification in a long-term hemodialysis patient.
    Kidney Int. 2026;109:401.
    PubMed    
    
    
    
41. KATO A, Shirai Y, Aihara Y, Miura K, et al
    Scurvy diagnosed in a patient undergoing peritoneal dialysis.
    Kidney Int. 2026;109:399.
    PubMed    
    
    
    
42. BERTRAND J, Dufour I, Lhommel R, Goffin E, et al
    Heart-shaped pelvic abscess in a patient undergoing peritoneal dialysis: a Valentine's Day surprise.
    Kidney Int. 2026;109:398.
    PubMed    
    
    
    January 2026
43. MILDERS J, Janse RJ, Bos WJW, Caskey FJ, et al
    A predictor finding study found patient-reported outcomes improve the prediction of mortality of incident dialysis patients.
    Kidney Int. 2026 Jan 21:S0085-2538(25)00677-5. doi: 10.1016/j.kint.2025.
    PubMed     Abstract available
    
    
    
44. KUPSCH C, Tsou S, Martin F, Wolff von Gudenberg R, et al
    Eligibility, Timing and Organ Quality: Indications and Outcomes of Kidney Transplantation in Older Patients.
    Kidney Int. 2026 Jan 21:S0085-2538(26)00052-9. doi: 10.1016/j.kint.2025.
    PubMed     Abstract available
    
    
    
45. YANG Y, Creon A, Levey AS, Faucon AL, et al
    Population-based estimated Glomerular Filtration Rate distributions and associated health outcomes provide opportunities for early identification of and primary prevention of chronic kidney disease.
    Kidney Int. 2026 Jan 16:S0085-2538(25)00989-5. doi: 10.1016/j.kint.2025.
    PubMed     Abstract available
    
    
    
46. 
    KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD).
    Kidney Int. 2026;109.
    PubMed    
    
    
    
47. BABITT JL, Berns JS, Bozkurt B, Cheung Khedairy RS, et al
    Executive Summary of the KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD).
    Kidney Int. 2026;109:44-56.
    PubMed     Abstract available
    
    
    December 2025
48. SIRIWARDANA A, Tangri N, Neuen B, Jardine M, et al
    UTILIZING RISK PREDICTION MODELS FOR OLDER PATIENTS WITH CHRONIC KIDNEY DISEASE.
    Kidney Int. 2025 Dec 24:S0085-2538(25)01015-4. doi: 10.1016/j.kint.2025.
    PubMed     Abstract available
    
    
    November 2025
49. HUGHES A, Gonzalez AM, van Zwieten A, Guha C, et al
    Establishing a core outcome measure for life participation in children with chronic kidney disease: a Standardised Outcomes in Nephrology - children and adolescents with chronic kidney disease (SONG-Kids) consensus workshop report.
    Kidney Int. 2025 Nov 25:S0085-2538(25)00887-7. doi: 10.1016/j.kint.2025.
    PubMed     Abstract available
    
    
    
50. CHRYSOSTOMOU C, Faustini F, Segelmark M, Carrero JJ, et al
    A national cohort study examined the risk of severe infection and infection-related mortality in patients with chronic kidney disease with lupus nephritis in comparison to other chronic kidney disease etiologies.
    Kidney Int. 2025 Nov 21:S0085-2538(25)00883-X. doi: 10.1016/j.kint.2025.
    PubMed     Abstract available
    
    
    
51. TANGRI N, Neuen BL, Cherney DZ, Tuttle KR, et al
    From Progression to Remission: A New Paradigm for Success in Chronic Kidney Disease.
    Kidney Int. 2025 Nov 6:S0085-2538(25)00847-6. doi: 10.1016/j.kint.2025.
    PubMed     Abstract available
    
    
    
52. SHUE I, Cherian R, Walker X, Slater K, et al
    The Case | Refractory hyperkalemia after ileostomy in a hemodialysis patient.
    Kidney Int. 2025;108:955-956.
    PubMed    
    
    
    
53. COZZI E
    Delisting of HLA antigens as a possible strategy to enable transplantation in highly sensitized patients with a cPRA >/= 99.9.
    Kidney Int. 2025;108:748-751.
    PubMed     Abstract available
    
    
    October 2025
54. SHROFF R, Schaefer F
    Optimizing cardiovascular outcomes in pediatric dialysis.
    Kidney Int. 2025 Oct 25:S0085-2538(25)00840-3. doi: 10.1016/j.kint.2025.
    PubMed     Abstract available
    
    
    
55. FURTH SL, Colhoun HM, Kanbay M, Kukla A, et al
    The relationship between obesity and chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2025 Oct 9:S0085-2538(25)00774-4. doi: 10.1016/j.kint.2025.
    PubMed     Abstract available
    
    
    
56. HARTZ W, Kinniry P
    Hypertriglyceridemia causing dialysis filter lipid deposition.
    Kidney Int. 2025;108:718.
    PubMed    
    
    
    
57. RAVI KS, Mc Causland FR
    Where next for potassium binders in hemodialysis?
    Kidney Int. 2025;108:534-536.
    PubMed     Abstract available
    
    
    
58. WONG G, Teixeira-Pinto A
    Redefining kidney failure: broadening metrics to realize equity in kidney care.
    Kidney Int. 2025;108:532-533.
    PubMed     Abstract available
    
    
    September 2025
59. SMOYER WE, Gillespie BS, Oni L, Nester C, et al
    STRATEGIES FOR THE DEVELOPMENT OF SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS FOR KIDNEY PROTECTION IN PEDIATRIC CHRONIC KIDNEY DISEASE: PROCEEDINGS OF A WORKSHOP MEETING IN JULY 2023.
    Kidney Int. 2025 Sep 24:S0085-2538(25)00747-1. doi: 10.1016/j.kint.2025.
    PubMed     Abstract available
    
    
    
60. CIROVIC A, Cirovic A
    Beyond fibroblast growth factor 23-fibroblast growth factor receptor 4: could aldosterone-driven iron deficiency impact cardiac remodeling in chronic kidney disease?
    Kidney Int. 2025;108:499.
    PubMed    
    
    
    August 2025
61. ITO H, Sato T, Sato F, Taniguchi Y, et al
    The Case | Acute neck swelling in a patient undergoing dialysis.
    Kidney Int. 2025;108:335-336.
    PubMed    
    
    
    
62. PIRBUCCUS M, Dufour I, Akachar Y, Goffin E, et al
    "Strawberry milkshake" effluent in a patient undergoing peritoneal dialysis.
    Kidney Int. 2025;108:331.
    PubMed    
    
    
    
63. PICCOLI GB, Orozco A, Shemies R, Attini R, et al
    Postpartum counseling and interventions to reduce the risk of chronic kidney disease: back to the future.
    Kidney Int. 2025;108:160-166.
    PubMed    
    
    
    July 2025
64. MURAKAMI N, Blosser CD, Webber AB, Gupta G, et al
    Management recommendations for kidney transplantation in patients with plasma cell dyscrasia.
    Kidney Int. 2025 Jul 28:S0085-2538(25)00576-9. doi: 10.1016/j.kint.2025.
    PubMed     Abstract available
    
    
    
65. FISHBANE S, Dember LM, Jadoul M, Kovesdy CP, et al
    The randomized DIALIZE-Outcomes trial evaluated sodium zirconium cyclosilicate in hemodialysis.
    Kidney Int. 2025 Jul 4:S0085-2538(25)00509-5. doi: 10.1016/j.kint.2025.
    PubMed     Abstract available
    
    
    
66. TEMPLE K, Lester R, Sinclair N, Owen K, et al
    Indigenous spirituality and cultural knowledges provide strength and resilience to Aboriginal people with chronic kidney disease.
    Kidney Int. 2025;108:2-4.
    PubMed    
    
    
    
67. AGARWAL R
    Steroidal or nonsteroidal mineralocorticoid receptor antagonists for reducing cardiovascular burden in chronic kidney disease.
    Kidney Int. 2025;108:11-14.
    PubMed    
    
    
    June 2025
68. RAILLON LA, Florens N, Payelle F, Martin M, et al
    Medium chain fatty acids are potent binding competitors to improve protein-bound uremic toxin clearance during hemodialysis.
    Kidney Int. 2025 Jun 25:S0085-2538(25)00492-2. doi: 10.1016/j.kint.2025.
    PubMed     Abstract available
    
    
    
69. ORTIZ A, Arreola Guerra JM, Chan JCN, Jha V, et al
    Preventing chronic kidney disease and maintaining kidney health: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2025 Jun 18:S0085-2538(25)00334-5. doi: 10.1016/j.kint.2025.
    PubMed     Abstract available
    
    
    
70. CUCCHIARI D, Mancebo-Sierra E, Caro JL, Meneghini M, et al
    A multicenter prospective cohort study evaluating impact of an active delisting strategy to enable kidney transplantation in wait-listed candidates with calculated Panel Reactive Antibody >/= 99.9.
    Kidney Int. 2025 Jun 6:S0085-2538(25)00427-2. doi: 10.1016/j.kint.2025.
    PubMed     Abstract available
    
    
    
71. RIZZOLO K, Villegas L, Cervantes L
    The national landscape of kidney transplantation for undocumented immigrants: advancing kidney transplantation equity.
    Kidney Int. 2025;107:976-979.
    PubMed     Abstract available
    
    
    
72. CHARYTAN DM, Winkelmayer WC, Granger CB, Middleton JP, et al
    Corrigendum to "Effects of dialysate potassium concentration of 3.0 mmol/l with sodium zirconium cyclosilicate on dialysis-free days versus dialysate potassium concentration of 2.0 mmol/l alone on rates of cardiac arrhythmias in hemodialysis patients
    Kidney Int. 2025;107:1123.
    PubMed    
    
    
    May 2025
73. MITROFANOVA A, Fontanella AM, Molina J, Zhang G, et al
    The enzyme SMPDL3b in podocytes decouples proteinuria from chronic kidney disease progression in experimental Alport Syndrome.
    Kidney Int. 2025 May 30:S0085-2538(25)00407-7. doi: 10.1016/j.kint.2025.
    PubMed     Abstract available
    
    
    
74. MUREA M, Torreggiani M, Deira J, Sirich TL, et al
    From Niche to Norm: A Multi-Action Plan to Close Gaps and Mainstream Incremental Hemodialysis.
    Kidney Int. 2025 May 20:S0085-2538(25)00404-1. doi: 10.1016/j.kint.2025.
    PubMed     Abstract available
    
    
    
75. DE BOER IH, Caramori ML, Chan JCN, Heerspink HJL, et al
    GLP-1 receptor agonists and other incretin mimetics for diabetes and chronic kidney disease-a KDIGO commentary.
    Kidney Int. 2025;107:767-771.
    PubMed    
    
    
    April 2025
76. LI F, Lan Q, Wang Y, Xiong J, et al
    Single-cell analysis of proximal tubular cells with different DNA content reveals functional heterogeneity in the acute kidney injury to chronic kidney disease transition.
    Kidney Int. 2025 Apr 21:S0085-2538(25)00332-1. doi: 10.1016/j.kint.2025.
    PubMed     Abstract available
    
    
    
77. ERICKSON KF, Fotheringham J
    Is online hemodiafiltration a cost-effective alternative to conventional hemodialysis?
    Kidney Int. 2025;107:602-605.
    PubMed     Abstract available
    
    
    March 2025
78. STACK AG
    Can we crystallize the role of urate-lowering treatment in chronic kidney disease?
    Kidney Int. 2025;107:394-396.
    PubMed     Abstract available
    
    
    
79. JENSEN M, Jensen BL
    Soluble guanylate cyclase as a direct target for pharmacologic mitigation of chronic kidney disease.
    Kidney Int. 2025;107:391-394.
    PubMed     Abstract available
    
    
    February 2025
80. BONNIN-MARQUEZ A, Jankowski J, Maas SL, Hermann J, et al
    Guanidinylation compromises the anti-inflammatory and anti-oxidative properties of apolipoprotein A-I in chronic kidney disease progression.
    Kidney Int. 2025 Feb 24:S0085-2538(25)00171-1. doi: 10.1016/j.kint.2025.
    PubMed     Abstract available
    
    
    
81. ZHU D, Judge PK, Wanner C, Haynes R, et al
    THE PREVENTION AND MANAGEMENT OF CHRONIC KIDNEY DISEASE AMONG PATIENTS WITH METABOLIC SYNDROME.
    Kidney Int. 2025 Feb 20:S0085-2538(25)00141-3. doi: 10.1016/j.kint.2024.
    PubMed     Abstract available
    
    
    
82. MENON G, Metoyer GT, Li Y, Chen Y, et al
    A national registry study evaluated the landscape of kidney transplantation among presumed unauthorized immigrants in the United States.
    Kidney Int. 2025 Feb 14:S0085-2538(25)00088-2. doi: 10.1016/j.kint.2025.
    PubMed     Abstract available
    
    
    
83. FUCHS MAA, Burke EJ, Latic N, Murray S, et al
    Fibroblast growth factor 23 and fibroblast growth factor receptor 4 promote cardiac metabolic remodeling in chronic kidney disease.
    Kidney Int. 2025 Feb 7:S0085-2538(25)00087-0. doi: 10.1016/j.kint.2025.
    PubMed     Abstract available
    
    
    
84. HSU SN, Stephen LA, Phadwal K, Dillon S, et al
    Mitochondrial dysfunction and mitophagy blockade contribute to renal osteodystrophy in chronic kidney disease-mineral bone disorder.
    Kidney Int. 2025 Feb 6:S0085-2538(25)00085-7. doi: 10.1016/j.kint.2025.
    PubMed     Abstract available
    
    
    
85. HUGHES A, Scholes-Robertson N, Coghlan D, Wu R, et al
    Identifying strategies for disseminating research to patients with chronic kidney disease and caregivers: a workshop report.
    Kidney Int. 2025 Feb 6:S0085-2538(25)00083-3. doi: 10.1016/j.kint.2025.
    PubMed     Abstract available
    
    
    January 2025
86. SCHOUTEN AEM, Fischer F, Blankestijn PJ, Vernooij RWM, et al
    A health economic evaluation of the multinational, randomized controlled CONVINCE trial - cost-utility of high-dose online hemodiafiltration compared to high-flux hemodialysis.
    Kidney Int. 2025 Jan 21:S0085-2538(25)00068-7. doi: 10.1016/j.kint.2024.
    PubMed     Abstract available
    
    
    
87. KETTELER M, Evenepoel P, Holden RM, Isakova T, et al
    Chronic kidney disease-mineral and bone disorder: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2025 Jan 10:S0085-2538(24)00810-X. doi: 10.1016/j.kint.2024.
    PubMed     Abstract available
    
    
    
88. HOLE B, Coast J, Caskey FJ, Selman LE, et al
    A choice experiment of older patients' preferences for kidney failure treatments.
    Kidney Int. 2025;107:130-142.
    PubMed     Abstract available
    
    
    
89. WATANABE S, Sawa N, Hiramatsu R, Oba Y, et al
    The Case | A patient with chronic kidney disease and new-onset heart failure.
    Kidney Int. 2025;107:195-196.
    PubMed    
    
    
    December 2024
90. MIMURA I, Chen Z, Natarajan R
    Epigenetic alterations and memory: key players in the development/progression of chronic kidney disease promoted by acute kidney injury and diabetes.
    Kidney Int. 2024 Dec 24:S0085-2538(24)00918-9. doi: 10.1016/j.kint.2024.
    PubMed     Abstract available
    
    
    
91. HANOUNEH M, Stewart S, Aktay R, Fang AS, et al
    Chylothorax and chylopericardium in a dialysis patient.
    Kidney Int. 2024;106:1190.
    PubMed    
    
    
    
92. BOBOT M, Burtey S
    New insights into mechanisms underlying cognitive impairment in chronic kidney disease.
    Kidney Int. 2024;106:1020-1022.
    PubMed     Abstract available
    
    
    November 2024
93. AMINI M, Frisch J, Jost P, Sarakpi T, et al
    Purinergic receptor P2X7 regulates interleukin-1alpha mediated inflammation in chronic kidney disease in a reactive oxygen species-dependent manner.
    Kidney Int. 2024 Nov 19:S0085-2538(24)00798-1. doi: 10.1016/j.kint.2024.
    PubMed     Abstract available
    
    
    
94. VAN DEN BERG CW, Dumas SJ, Little MH, Rabelink TJ, et al
    Challenges in maturation and integration of kidney organoids for stem cell-based renal replacement therapy.
    Kidney Int. 2024 Nov 19:S0085-2538(24)00806-8. doi: 10.1016/j.kint.2024.
    PubMed     Abstract available
    
    
    
95. KO TY, Wu CC, Hsieh MY, Yang CW, et al
    A randomized controlled trial evaluated the efficacy and safety of apixaban for prevention of recurrent thrombosis after thrombectomy of hemodialysis vascular access.
    Kidney Int. 2024 Nov 15:S0085-2538(24)00792-0. doi: 10.1016/j.kint.2024.
    PubMed     Abstract available
    
    
    
96. GHANG B, Park J, Lee JS, Lim JS, et al
    Post-hoc analysis of the CARES trial suggests delayed progression of chronic kidney disease in patients with gout during urate-lowering therapy.
    Kidney Int. 2024 Nov 15:S0085-2538(24)00789-0. doi: 10.1016/j.kint.2024.
    PubMed     Abstract available
    
    
    
97. GEORGERY H, Lengele JP, Leflot S, Gillion V, et al
    Recurrent iodine-induced sialadenitis in a patient undergoing hemodialysis: is this really ineluctable?
    Kidney Int. 2024;106:997.
    PubMed    
    
    
    
98. HAMDAN H, Roshanravan B
    Dialysis modality and quality of life: more answers yet more questions.
    Kidney Int. 2024;106:792-794.
    PubMed     Abstract available
    
    
    
99. SHAREEF Z, Spradling M, Blair P, Quinones-Vargas I, et al
    Appendicitis associated with sevelamer use in a patient receiving peritoneal dialysis.
    Kidney Int. 2024;106:1000.
    PubMed    
    
    
    
100. YANAGI T, Kikuchi H, Takeuchi K, Susa K, et al
     ULK1-regulated AMP sensing by AMPK and its application for the treatment of chronic kidney disease.
     Kidney Int. 2024;106:887-906.
     PubMed     Abstract available
     
     
     October 2024
101. IKIZLER TA, Drueke TB, Floege J, Wong G, et al
     Avoiding Arrythmias by Personalizing Dialysate Concentration: A Case for Precision Medicine in Dialysis Patients.
     Kidney Int. 2024 Oct 22:S0085-2538(24)00721-X. doi: 10.1016/j.kint.2024.
     PubMed     Abstract available
     
     
     
102. CHARYTAN DM, Winkelmayer WC, Granger CB, Middleton JP, et al
     Effects of dialysate potassium concentration of 3.0mEq/l with sodium zirconium cyclosilicate on dialysis-free days versus dialysate potassium concentration of 2.0mEq/l alone on rates of cardiac arrhythmias in hemodialysis patients with hyperkalemia.
     Kidney Int. 2024 Oct 22:S0085-2538(24)00722-1. doi: 10.1016/j.kint.2024.
     PubMed     Abstract available
     
     
     
103. BAJAJ A, Arora M, Bhatt U
     The Case | Dark dialysate after colonoscopy.
     Kidney Int. 2024;106:761-762.
     PubMed    
     
     
     
104. SHARMA Y, Tiwari V, Tyagi V, Bhargava V, et al
     CAPD catheter obstruction by fallopian tubes.
     Kidney Int. 2024;106:760.
     PubMed    
     
     
     
105. CHEN WLJ, Fung KFK, Chan EY
     Nephronophthisis-associated ciliopathy with brachydactyly, medullary cysts, and chronic kidney disease.
     Kidney Int. 2024;106:759.
     PubMed    
     
     
     September 2024
106. BISHOP NC
     Unpicking the multi-omic response to endurance training: relevance for exercise benefits in chronic kidney disease.
     Kidney Int. 2024 Sep 18:S0085-2538(24)00646-X. doi: 10.1016/j.kint.2024.
     PubMed    
     
     
     
107. TONG KC, Wee KW
     Cardiovascular disease as a risk factor for frailty in dialysis patients.
     Kidney Int. 2024;106:537-538.
     PubMed    
     
     
     
108. GARG AX, Young A
     Improving the management of chronic kidney disease in primary care by enhancing laboratory reports with additional information and follow-up procedures.
     Kidney Int. 2024;106:366-368.
     PubMed     Abstract available
     
     
     August 2024
109. BERGERON NAD, Candellier A, Rousseau-Gagnon M, Mac-Way F, et al
     Unusual cause of retroperitoneal leak in a patient undergoing peritoneal dialysis.
     Kidney Int. 2024;106:321.
     PubMed    
     
     
     
110. TOUSSAINT ND, Badve SV
     Normalizing serum phosphate based on association, not causation? Lessons in dialysis should have taught us not to fix what we can't prove is broken.
     Kidney Int. 2024;106:195-199.
     PubMed    
     
     
     
111. HAMANO T, Fukagawa M
     Results of the EPISODE trial plead for reasonable practice-based serum phosphate lowering in patients on dialysis.
     Kidney Int. 2024;106:191-195.
     PubMed    
     
     
     July 2024
112. ROSE M, Fischer FH, Liegl G, Strippoli GF, et al
     The CONVINCE randomized trial found positive effects on quality of life for patients with chronic kidney disease treated with hemodiafiltration.
     Kidney Int. 2024 Jul 30:S0085-2538(24)00534-9. doi: 10.1016/j.kint.2024.
     PubMed     Abstract available
     
     
     
113. ZIMMERMANN S, Mathew A, Bondareva O, Elwakiel A, et al
     Chronic kidney disease leads to microglial potassium efflux and inflammasome activation in the brain.
     Kidney Int. 2024 Jul 30:S0085-2538(24)00535-0. doi: 10.1016/j.kint.2024.
     PubMed     Abstract available
     
     
     
114. JOHNSON RJ, Mandell BF, Schlessinger N, Mount DB, et al
     Controversies and practical management of patients with gout and chronic kidney disease.
     Kidney Int. 2024 Jul 19:S0085-2538(24)00473-3. doi: 10.1016/j.kint.2024.
     PubMed     Abstract available
     
     
     
115. STAMELLOU E, Noels H, Floege J
     Factor XI inhibition in hemodialysis patients: the safer anticoagulation?
     Kidney Int. 2024;106:21-23.
     PubMed     Abstract available
     
     
     
116. SAHINOZ M, Ikizler TA
     Inflammasome activation: unraveling the link between chronic kidney disease and atrial fibrillation.
     Kidney Int. 2024;106:6-9.
     PubMed    
     
     
     
117. MEDINA RANGEL PX, Ishibe S
     Preventing MMP23-mediated cleavage of podocyte RARRES1: a novel strategy to halt chronic kidney disease progression?
     Kidney Int. 2024;106:16-18.
     PubMed     Abstract available
     
     
     
118. WONG G, Guha C, Mallitt KA, van Zwieten A, et al
     The randomized controlled trial (NAVKIDS2) of a patient navigator program created for children with chronic kidney disease.
     Kidney Int. 2024 Jul 1:S0085-2538(24)00450-2. doi: 10.1016/j.kint.2024.
     PubMed     Abstract available
     
     
     May 2024
119. CORKEN AL, Ong V, Kore R, Ghanta SN, et al
     Platelets, Inflammation, and Purinergic Receptors in Chronic Kidney Disease.
     Kidney Int. 2024 May 29:S0085-2538(24)00381-8. doi: 10.1016/j.kint.2024.
     PubMed     Abstract available
     
     
     
120. CHAN GC, Kalantar-Zadeh K, Ng JK, Tian N, et al
     Frailty in Patients on Dialysis.
     Kidney Int. 2024 May 3:S0085-2538(24)00315-6. doi: 10.1016/j.kint.2024.
     PubMed     Abstract available
     
     
     
121. GOLDSTEIN CE, Taljaard M, Nicholls SG, Beaucage M, et al
     The Ottawa Statement implementation guidance document for cluster randomized trials in the hemodialysis setting.
     Kidney Int. 2024;105:898-911.
     PubMed     Abstract available
     
     
     
122. CULLIS B, McCulloch M, Finkelstein FO
     Development of PD in lower-income countries: a rational solution for the management of AKI and ESKD.
     Kidney Int. 2024;105:953-959.
     PubMed     Abstract available
     
     
     April 2024
123. WONG G, Bernier-Jean A, Rovin B, Ronco P, et al
     Time for Action: Recognising chronic kidney disease as a major non-communicable disease driver of premature mortality.
     Kidney Int. 2024 Apr 2:S0085-2538(24)00247-3. doi: 10.1016/j.kint.2024.
     PubMed    
     
     
     
124. 
     KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.
     Kidney Int. 2024;105.
     PubMed    
     
     
     
125. LEVIN A, Ahmed SB, Carrero JJ, Foster B, et al
     Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns.
     Kidney Int. 2024;105:684-701.
     PubMed     Abstract available
     
     
     March 2024
126. WINKELMAYER WC, Lensing AWA, Thadhani RI, Mahaffey KW, et al
     A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysis.
     Kidney Int. 2024 Mar 25:S0085-2538(24)00196-0. doi: 10.1016/j.kint.2024.
     PubMed     Abstract available
     
     
     
127. PIETERS TT, Besseling PJ, Bovee DM, Rookmaaker MB, et al
     Discrepancies between transcutaneous and estimated glomerular filtration rates in rats with chronic kidney disease.
     Kidney Int. 2024 Mar 19:S0085-2538(24)00187-X. doi: 10.1016/j.kint.2024.
     PubMed     Abstract available
     
     
     
128. GILL JS, Chadban SJ
     Pretransplant screening for coronary artery disease: data are required before practice change.
     Kidney Int. 2024;105:470-472.
     PubMed     Abstract available
     
     
     February 2024
129. LEE J, Lee J, Kim K, Lee J, et al
     Antibiotic-induced intestinal microbiota depletion can attenuate the acute kidney injury to chronic kidney disease transition via NADPH oxidase 2 and trimethylamine-N-oxide inhibition.
     Kidney Int. 2024 Feb 29:S0085-2538(24)00163-7. doi: 10.1016/j.kint.2024.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Chronic Renal Failure is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum